Takeda Pharmaceutical Non-GAAP EPS of ¥428.00, revenue of ¥3411.2B; updates FY26 outlook
Source: SeekingAlpha
2026-01-29 01:51:15 ET
More on Takeda Pharmaceutical
- Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Takeda Pharmaceutical Company Limited (TAK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Takeda: Lack Of Realistic Upside In Japanese Pharma
- Halozyme, Takeda in arrangement to use former's drug delivery tech in Entyvio
- Takeda, XOMA ink new royalty agreement; amend existing deal
Read the full article on Seeking Alpha
For further details see:
Takeda Pharmaceutical Non-GAAP EPS of ¥428.00, revenue of ¥3411.2B; updates FY26 outlook
Takeda Pharmaceutical Co Ltd
NASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$34.662 Last:
171 Volume:
$34.662 Open:
TKPHF Latest News
TKPHF Stock Data
$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
